Pacific Biosciences of California, Inc. Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31)
Pacific Biosciences of California, Inc. (PACB) had Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) of $112.31 million as of 2013-03-31, per its 10-Q filed 2013-05-10.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesFairValueDisclosure · last filed 2013-05-10
- 2013-03-31: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $112.31M.
- 2012-12-31: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $100.58M.
- 2012-09-30: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $32.56M.
- 2012-06-30: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $33.62M.
| Period end | Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) | Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) as first filed |
|---|---|---|
| 2013-03-31 | $112.31M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $100.58M 10-Q · filed 2013-05-10 | |
| 2012-09-30 | $32.56M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $33.62M 10-Q · filed 2012-08-07 | |
| 2011-12-31 | $177.43M 10-K · filed 2013-03-15 | $58.87M 10-Q · filed 2012-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |